FF301 第 1 頁 共 10 頁 v 1.1.0 呈交日期: 2024年9月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01336 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,034,107,260 | RMB | | | 1 RMB | | 1,034,107,260 | | 增加 / 減少 (-) | | | | | | | RMB | | | | 本月底結存 | | | 1,034,107,260 | RMB | | | 1 RMB | | 1,034,107,260 | | 2. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | - ...

Investment Rating - The report maintains a "Buy" rating for both A-shares and H-shares of the company, with current prices at 33.05 RMB and 16.92 HKD respectively [2]. Core Insights - The company experienced a significant increase in net profit, with a year-on-year growth of 11.1% to 110.8 billion RMB in the first half of 2024, driven by improved investment performance and a doubling of quarterly profits [5][7]. - New business value (NBV) surged by 57.7% year-on-year to 39.0 billion RMB, supported by an increase in the proportion of long-term insurance premiums and enhanced pricing strategies [7][12]. - The company has implemented a comprehensive health and wellness service system, which is expected to synergize with its life insurance business, potentially boosting sales of protection-oriented products [12]. Financial Performance - In the first half of 2024, the company reported total revenue of 555.9 billion RMB, a 13.6% increase year-on-year, while insurance service revenue decreased by 11.9% to 234.2 billion RMB [5]. - The annualized net investment return rate was 3.2%, a slight decrease of 0.2 percentage points year-on-year, but the total investment return rate improved by 1.1 percentage points to 4.8% [5][7]. - The company plans to distribute a mid-term dividend of 0.54 RMB per share, marking its first implementation of such a dividend policy [5]. Business Development - The individual insurance channel has seen a significant enhancement in productivity, with a 28.3% year-on-year increase in average per capita productivity [6]. - The company is focusing on transforming its individual insurance channel and optimizing its product offerings, which is expected to lead to sustained growth in NBV throughout the year [12]. - The report highlights the challenges faced in the bancassurance channel, where first-year premiums for long-term insurance dropped by 60.8% year-on-year due to regulatory impacts, although the decline has moderated compared to the first quarter [6][7].

Investment Rating - The investment rating for the company is "Buy" (maintained) [6][8] Core Insights - The company reported a significant increase in NBV and net profit for the first half of 2024, with NBV reaching 3.902 billion yuan, a year-on-year growth of 57.7%, and net profit at 11.083 billion yuan, up 11.1% year-on-year [3][7] - The improvement in NBV growth is attributed to a notable enhancement in new business value rates, with the NBV margin increasing to 18.8%, up 12 percentage points year-on-year [7] - The company's total investment income rose by 43.3% to 31.61 billion yuan, driven by an increase in fair value changes [7] Financial Performance Summary - For 2024H1, the company achieved a NBV of 39.02 billion yuan, with a year-on-year increase of 57.7% [7] - The net profit for 2024H1 was 110.83 billion yuan, reflecting a year-on-year growth of 11.1% [7] - The company's annualized net, total, and comprehensive investment returns for 2024H1 were 3.2%, 4.8%, and 6.5%, respectively [7] - The expected net profit for 2024-2026 is projected to be 12.6 billion yuan, 14.1 billion yuan, and 16.4 billion yuan, with corresponding growth rates of 45%, 12%, and 16% [8]

Financial Performance - The company reported a net profit attributable to shareholders of CNY 11.08 billion, reflecting an 11.1% increase compared to the previous year[31]. - The total comprehensive income for the first half of 2024 was -12.384 billion yuan, a significant decline compared to 1.338 billion yuan in the same period of 2023[39]. - The company's net profit for the first half of 2024 was RMB 11,928 million, compared to RMB 10,716 million for the same period in 2023, representing an increase of approximately 11.3%[179]. - The company's total equity attributable to shareholders decreased to RMB 90,025 million as of June 30, 2024, from RMB 105,067 million at the end of 2023, a decline of about 14.3%[176]. - The company reported a significant increase in fair value gains, with RMB 14,881 million for the first half of 2024, compared to RMB 7,089 million in the same period of 2023, reflecting a growth of approximately 109.5%[179]. Investment and Asset Management - The investment scale reached CNY 1,438.99 billion, a 7.0% increase from the previous year, with an annualized total investment return rate of 4.8% and a comprehensive investment return rate of 6.5%[19]. - The total investment assets reached 1.438 trillion yuan, reflecting a growth of 7.0% compared to the end of 2023, with a significant increase in long-term equity investments by 214.8%[62]. - The company’s investment in technology innovation reached CNY 41.88 billion, a year-on-year growth of 41.1%[26]. - The company has a diversified investment strategy, including asset management and project investments, to enhance its financial performance[91]. - The company’s investment activities generated a net cash outflow of 32,019 million RMB, a significant reduction of 58.3% compared to the previous year[78]. Risk Management - The company faces various risks including market risk, credit risk, insurance risk, operational risk, reputational risk, strategic risk, and liquidity risk, and has implemented measures to manage these risks effectively[4]. - The company plans to strengthen its risk management framework in response to ongoing economic and regulatory challenges, ensuring effective risk monitoring in key areas[94][95]. - The company closely monitors liquidity risks associated with policyholder withdrawals and market fluctuations[79]. - The company acknowledges potential risks from a complex international environment and low domestic interest rates, which may pressure investment returns[94]. Dividend and Shareholder Information - The company plans to distribute a mid-term cash dividend of RMB 0.54 per share, totaling approximately RMB 1.685 billion, pending shareholder approval[4]. - The company distributed 70% of the surplus from the dividend business to policyholders[109]. - The total number of shares remained unchanged at 3,119,546,600, with 66.85% being unrestricted circulating shares and 33.15% being H-shares[151]. - The company had 80,454 shareholders at the end of the reporting period, with the top ten shareholders holding a combined 62.52% of the total shares[154]. Business Development and Strategy - The company aims to strengthen its asset management business while promoting the development of the pension and health industries[16]. - The company aims to enhance core competitiveness by focusing on product competitiveness, team optimization, technology empowerment, and diversified service ecosystems[93]. - The company has launched three new products supporting individual pension business as of June 2024[135]. - The company has established a nationwide sales and service network to provide comprehensive life insurance products and services to both individual and institutional clients[16]. Operational Performance - The company processed a total of 2.36 million claims with a total payout amount of CNY 7.3 billion, averaging 13,100 claims per day[27]. - The company’s insurance service performance decreased by 8.3% year-on-year, with insurance service income dropping by 11.9% due to reduced contract service margin amortization[57]. - The health insurance segment generated premium income of 2.9183 billion yuan, down 2.9% year-on-year, with first-year premium income declining by 20.8%[50]. - The company’s weighted average return on equity increased by 2.53 percentage points to 11.21%[32]. Employee and Social Responsibility - As of June 30, 2024, the company has a total of 30,221 employees across its main company and 35 subsidiaries[132]. - The company has a volunteer team of 34,709 members, completing 2,113 volunteer activities with a total service duration of 46,288.5 hours[137]. - The company provided 10 million CNY of insurance coverage to over 940,000 sanitation workers through its public welfare project[137]. - The company received the "2024 Golden Bee Corporate Social Responsibility - ESG Competitiveness - Rural Revitalization" award[136].

A股股票代码：601336 A股股票简称：新华保险 编号：2024-040号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 2024年度中期利润分配方案公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 重要内容提示： 一、利润分配方案内容 经德勤华永会计师事务所（特殊普通合伙）审阅，新华人寿保险股份有限公 司（以下简称"公司"）2024 年中期母公司财务报表净利润为 107.95 亿元（人 民币，下同），合并财务报表归属于母公司股东的净利润为 110.83 亿元。截至 2024 年 6 月 30 日，母公司以前年度未分配利润累计为 860.77 亿元，无未弥补亏 损。经董事会决议，公司 2024 年中期拟以实施权益分派股权登记日登记的总股 本为基数分配利润。本次利润分配方案如下： 公司于 2024 年 8 月 29 日召开的第八届董事会第二十四次会议审议通过了 《关于 2024 年度中期利润分配方案的议案》，同意本次利润分配方案并同意将 该方案提交公司股东大会审议。 公司 ...

1、公司上述报告的编制和审议程序符合法律、行政法规、中国证券监督管 理委员会和《公司章程》的规定； 2、公司上述报告内容真实、准确、完整地反映了公司的实际情况； 3、在提出本意见前，监事会未发现参与公司上述报告编制和审议的人员有 违反保密规定的行为； 4、公司上述报告所载公司 2024 年度中期利润分配方案考虑到公司的长远 和可持续发展、盈利规模、投资资金需求、集团及公司偿付能力状况等情况，平 衡业务持续发展与股东综合回报之间的关系，符合公司的利润分配政策。 A股股票代码：601336 A股股票简称：新华保险 编号：2024-039号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 第七届监事会第四十七次会议决议公告 新华人寿保险股份有限公司监事会及全体监事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"公司"）于 2024 年 8 月 19 日以电子 邮件方式向全体监事发出第七届监事会第四十七次会议（以下简称"会议"）通知 和材料，会议于 2024 年 8 月 29 日在北京市以 ...

新华人寿保险股份有限公司 第八届董事会第二十四次会议决议公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"公司"）于 2024 年 8 月 15 日以电子 邮件方式向全体董事发出第八届董事会第二十四次会议（以下简称"会议"）通知 和材料，会议于 2024 年 8 月 29 日在北京市以现场方式召开。会议应到董事 11 人，现场出席董事 11 人，公司监事和高级管理人员列席了会议。会议的召集、 召开符合《中华人民共和国公司法》《新华人寿保险股份有限公司章程》和《新 华人寿保险股份有限公司董事会议事规则》的有关规定，所作的决议合法、有效。 会议由董事长杨玉成主持，经与会董事审议和现场表决，形成如下会议决议： 一、审议通过了《关于 2024 年中期报告（A 股/H 股）的议案》。 公司董事会审计与关联交易控制委员会已审议通过此项议案。 具体内容详见公司同日于上海证券交易所网站（www.sse.com.cn）披露的《新 华保险 2024 年半年度报告》。 表决情况：同意 11 ...

A股股票代码：601336 A股股票简称：新华保险 编号：2024-037号 H股股票代码： 01336 H股股票简称：新华保险 新华人寿保险股份有限公司 关于召开2024年中期业绩发布会的公告 本公司拟于 2024 年 8 月 30 日在上海证券交易所网站（www.sse.com.cn）披 露本公司 2024 年半年度报告。为了便于广大投资者更全面深入地了解本公司 2024 年中期业绩和经营情况，本公司拟于 2024 年 8 月 30 日 15:00-16:30 通过网 络直播的方式召开业绩发布会，就投资者普遍关心的问题进行交流。 二、业绩发布会召开的时间、地点 （三）网络直播地址：https://s.comein.cn/AH4zx 三、本公司出席人员 本公司董事长杨玉成，总裁张泓，副总裁、临时财务负责人、总精算师兼董 1 会议召开时间：2024 年 8 月 30 日（星期五）15:00-16:30 会议召开方式：网络直播 网络直播地址：https://s.comein.cn/AH4zx 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本通告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本通告全部或任何部分內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 董事會會議通告 新華人壽保險股份有限公司（「本公司」）董事會（「董事會」）謹此宣佈， 本公司將於二零二四年八月二十九日（星期四）舉行董事會會議，藉以(其中包 括)考慮及批准本公司及其附屬公司截至二零二四年六月三十日止六個月之中期 業績及其發佈，並考慮派發中期股息，以及處理其他事項。 承董事會命 新華人壽保險股份有限公司 楊玉成 董事長 中國北京，二零二四年八月十六日 於本通告日期，本公司董事長、執行董事為楊玉成；執行董事為張泓；非執行 董事為楊毅、何興達、楊雪、胡愛民和李琦強；獨立非執行董事為馬耀添、賴 觀榮、徐徐和郭永清。 ...

| A股股票代码：601336 | A股股票简称：新华保险 编号：2024-036号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 新华人寿保险股份有限公司 保费收入公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 根据中华人民共和国财政部《企业会计准则第 25 号——原保险合同》（财 会〔2006〕3 号）及《保险合同相关会计处理规定》（财会〔2009〕15 号），新华 人寿保险股份有限公司（以下简称"公司"）于 2024 年 1 月 1 日至 2024 年 7 月 31 日期间累计原保险保费收入为人民币 11,187,460 万元。公司业务结构持续优 化，十年期及以上期交保费稳步增长，新业务价值快速提升，绩优人力发展向好， 公司高质量发展动能进一步增强。 上述原保险保费收入数据未经审计，提请投资者注意。 特此公告。 新华人寿保险股份有限公司董事会 2024 年 8 月 16 日 ...